Goldman Sachs’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $130M | Sell |
566,192
-30,511
| -5% | -$6.84M | 0.02% | 886 |
|
|
2025
Q4 | $127M | Sell |
596,703
-56,309
| -9% | -$11.6M | 0.02% | 850 |
|
|
2025
Q3 | $130M | Buy |
653,012
+114,725
| +21% | +$21.4M | 0.02% | 789 |
|
|
2025
Q2 | $92.9M | Sell |
538,287
-47,294
| -8% | -$7.7M | 0.02% | 924 |
|
|
2025
Q1 | $91.3M | Buy |
585,581
+55,164
| +10% | +$7.88M | 0.02% | 827 |
|
|
2024
Q4 | $73M | Buy |
530,417
+40,066
| +8% | +$5.27M | 0.01% | 1000 |
|
|
2024
Q3 | $73.2M | Buy |
490,351
+68,800
| +16% | +$9.29M | 0.01% | 957 |
|
|
2024
Q2 | $57.5M | Sell |
421,551
-15,541
| -4% | -$2.11M | 0.01% | 1071 |
|
|
2024
Q1 | $66.1M | Buy |
437,092
+14,238
| +3% | +$2.03M | 0.01% | 1000 |
|
|
2023
Q4 | $53.3M | Buy |
422,854
+12,881
| +3% | +$1.28M | 0.01% | 1142 |
|
|
2023
Q3 | $38.4M | Buy |
409,973
+12,882
| +3% | +$1.21M | 0.01% | 1281 |
|
|
2023
Q2 | $35.4M | Sell |
397,091
-2,151,054
| -84% | -$187M | 0.01% | 1349 |
|
|
2023
Q1 | $273M | Buy |
2,548,145
+28,633
| +1% | +$3.28M | 0.07% | 316 |
|
|
2022
Q4 | $308M | Sell |
2,519,512
-338,918
| -12% | -$39.3M | 0.09% | 273 |
|
|
2022
Q3 | $295M | Sell |
2,858,430
-457,785
| -14% | -$43.4M | 0.09% | 253 |
|
|
2022
Q2 | $308M | Buy |
3,316,215
+1,561,757
| +89% | +$147M | 0.09% | 234 |
|
|
2022
Q1 | $206M | Buy |
1,754,458
+1,698,302
| +3,024% | +$197M | 0.05% | 425 |
|
|
2021
Q4 | $7.55M | Buy |
56,156
+25,188
| +81% | +$3.75M | ﹤0.01% | 3016 |
|
|
2021
Q3 | $4.94M | Sell |
30,968
-123,203
| -80% | -$16.9M | ﹤0.01% | 3376 |
|
|
2021
Q2 | $20.3M | Buy |
154,171
+81,338
| +112% | +$10.8M | 0.01% | 2039 |
|
|
2021
Q1 | $9.39M | Buy |
72,833
+3,718
| +5% | +$565K | ﹤0.01% | 2623 |
|
|
2020
Q4 | $11.5M | Buy |
69,115
+24,443
| +55% | +$4.04M | ﹤0.01% | 2335 |
|
|
2020
Q3 | $6.89M | Sell |
44,672
-6,961
| -13% | -$1M | ﹤0.01% | 2643 |
|
|
2020
Q2 | $7.64M | Buy |
51,633
+7,191
| +16% | +$987K | ﹤0.01% | 2459 |
|
|
2020
Q1 | $5M | Buy |
44,442
+25,819
| +139% | +$3.35M | ﹤0.01% | 2641 |
|
|
2019
Q4 | $2.59M | Sell |
18,623
-23,251
| -56% | -$2.58M | ﹤0.01% | 3466 |
|
|
2019
Q3 | $4.03M | Buy |
41,874
+24,357
| +139% | +$2.72M | ﹤0.01% | 3026 |
|
|
2019
Q2 | $2.02M | Sell |
17,517
-3,649
| -17% | -$437K | ﹤0.01% | 3551 |
|
|
2019
Q1 | $2.49M | Sell |
21,166
-12,934
| -38% | -$1.13M | ﹤0.01% | 3474 |
|
|
2018
Q4 | $2.14M | Buy |
34,100
+18,565
| +120% | +$1.17M | ﹤0.01% | 3485 |
|
|
2018
Q3 | $1.1M | Sell |
15,535
-10,567
| -40% | -$727K | ﹤0.01% | 3995 |
|
|
2018
Q2 | $1.74M | Buy |
26,102
+648
| +3% | +$42.6K | ﹤0.01% | 3712 |
|
|
2018
Q1 | $1.67M | Buy |
25,454
+9,221
| +57% | +$518K | ﹤0.01% | 3722 |
|
|
2017
Q4 | $650K | Buy |
+16,233
| New | +$590K | ﹤0.01% | 4621 |
|
Other funds holding ASND
RCM
ACA
